Tag #Metsera

Showing 1 to 3 of 3 results

themarker.com
🌐 85% Global Worthiness
News related image

Pfizer to Acquire Metsera for $7.3 Billion

Pfizer is close to acquiring the weight-loss drug startup Metsera for $7.3 billion, marking Pfizer's first major acquisition in two years and a significant entry into the lucrative weight-loss drug market.

Progress

32% Bias Score

Good Health and Well-being
it.euronews.com
🌐 85% Global Worthiness
News related image

Pfizer Acquires Metsera for $4.9 Billion to Enter Obesity Drug Market

Pfizer, the US pharmaceutical giant, has acquired the biopharmaceutical company Metsera for $4.9 billion to enter the obesity drug market, gaining access to Metsera's pipeline of obesity and cardiometabolic therapies.

Progress

40% Bias Score

Good Health and Well-being
euronews.com
🌐 85% Global Worthiness
News related image

Pfizer to Acquire Metsera for $4.9 Billion to Enter Obesity Drug Market

Pfizer announced a $4.9 billion cash acquisition of Metsera, a biopharmaceutical firm with a pipeline of obesity and cardiometabolic disease treatments, to expand into the growing obesity drug market.

Progress

44% Bias Score

Good Health and Well-being

Showing 1 to 3 of 3 results